Nachrichten zur Hikma Pharmaceuticals PLC Aktie

Hikma Pharmaceuticals PLC (HKMPF) Q2 2024 Pre-Recorded Presentation Transcript

…

Hikma Pharmaceuticals shares surge on upbeat guidance By Investing.com

Hikma Pharmaceuticals shares surge on upbeat guidance…

Hikma Pharmaceuticals rallies following bullish first-half earnings

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) shares bounced 7.6% higher on Thursday following publication of its half-year financial report. “We had…

Hikma beefs up complex manufacturing skillset with Xellia assets

Hikma Pharmaceuticals has bought a raft of US injectable or finished dosage form (FDF) assets from Copenhagen-based Xellia Pharmaceuticals for US$135...…

Hikma Pharma buys Xellia assets for US$135m

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) has bought a raft of US injectable or finished dosage form (FDF) assets from Copenhagen-based…

Hikma Pharmaceuticals PLC (HKMPF) Q4 2023 Earnings Call Transcript

…

Hikma divi boost sends stock 5% higher

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF)s shares rose 5% in early trade on Thursday, buoyed by robust annual results that prompted the…

FTSE 100 LIVE: Stocks rally led by Rolls Royce and Beazley, but Lloyds slips

The FTSE 100 has got off to a good start, as expected, led by strong gains for Rolls-Royce and Hikma Pharmaceuticals.…

Hikma Pharma resolves US opioid litigation

Shares in Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) rose then fell into the red after it announced overnight that it has agreed a…

Hikma Pharmaceuticals upgrades guidance for all segments except injectables

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) has upgraded its full-year guidance for two out of three of its business segments following…

Optic Neuritis Treatment Market revenue to hit USD 450 Million by 2035, says Research Nester

Prominent Optic Neuritis Treatment Market players include Santen Pharmaceutical Co., Ltd., Mallinckrodt plc, AbbVie Inc., Novartis AG, Sanofi Group, AdvaCare…

Specialty Generics Market to Reach USD 184.8 Billion by 2032; Increasing Capacity for Walking & Physical Activities to Propel Growth, says The Brainy Insights

Global specialty generics market size from USD 70.0 billion in 2022 to USD 184.8 billion, growing at a CAGR of…

SK Biopharmaceuticals signs license deal to introduce its epilepsy med in the Middle East, Africa

SK Biopharmaceuticals announced Friday that it had signed an out-licensing deal with Hikma MENA FZE, the Middle East and North…

Hikma Appoints Bill Larkins as President of Injectables Business

Hikma Appoints Bill Larkins as President of Injectables Business...…

Hikma Pharmaceuticals goes ex dividend tomorrow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Hikma Pharmaceuticals GAAP EPS of $59.30, revenue of $1.43B

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Hikma posts higher interim revenue; ups guidance for Generics business

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics

LONDON (dpa-AFX) - Hikma Pharmaceuticals PLC (HIK, HIK.L) reported Thursday that its first-half profit attributable to shareholders fell 24 percent…

UK drugmaker Hikma raises annual outlook for generics arm

...Aug 3 (Reuters) - British drugmaker Hikma Pharmaceuticals on Thursday......…

Hikma Pharmaceutical 1H EPS 59.0c

Hikma Pharmaceutical 1H EPS 59.0c...…

Shares in Pfizer rivals Hikma, Fresenius rally after tornado hits factory

...By Lucy Raitano LONDON (Reuters) - Shares in UK pharmaceutical... for comment when contacted by Reuters. European healthcare…

BRIEF-Hikma Launches Diazepam Injection, USP In US

...May 2 (Reuters) - Hikma Pharmaceuticals PLC: * HIKMA - LAUNCHES......…

Hikma Pharmaceuticals Says Begins 2023 With Firm Performance

LONDON (dpa-AFX) - Hikma Pharmaceuticals Plc (HIK, HIK.L), a British multinational pharmaceutical company, said in a trading update on Friday…

Hikma Sees Strong Start to 2023; Hikes Generics Unit Guidance

Hikma Sees Strong Start to 2023; Hikes Generics Unit Guidance...…

Hikma Pharmaceutical appoints Injectables lead Mishlawi as new CEO

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-Hikma Pharma names Mishlawi as next CEO

...(Adds details on new CEO) April 12 (Reuters) - Generic drugmaker......…

Hikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1

LONDON (dpa-AFX) - Hikma Pharmaceuticals PLC (HIK, HIK.L) announced Wednesday that it has appointed Riad Mishlawi, President of the Groups…

Hikma Pharmaceuticals Appoints Riad Mishlawi CEO

Hikma Pharmaceuticals Appoints Riad Mishlawi CEO...…

Hikma Pharma names Mishlawi as next CEO

...April 12 (Reuters) - Hikma Pharmaceuticals Plc said on Wednesday Riad......…

Hikma Pharmaceuticals 2022 Earnings Fell But Beat Core Profit Forecasts -- 2nd Update

Hikma Pharmaceuticals 2022 Earnings Fell But Beat Core Profit Forecasts -- 2nd Update...…

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up

LONDON (dpa-AFX) - Shares of Hikma Pharmaceuticals PLC (HIK, HIK.L) were gaining around 4 percent in the early morning trading…

Hikma Pharmaceuticals 2022 Net Profit Misses Consensus on Lower Generics Earnings -- Update

Hikma Pharmaceuticals 2022 Net Profit Misses Consensus on Lower Generics Earnings -- Update...…

Hikma Pharmaceutical FY EPS 83.6c

Hikma Pharmaceutical FY EPS 83.6c...…

Hikma accuses Amarin of suppressing generic versions of heart pill

...By Brendan Pierson (Reuters) - Generic drugmaker Hikma......…

Arecor transfers AT307 drug to Hikma for development, regains AT282

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hikma Pharmaceuticals higher as Citi analysts revise target price

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Celltrion Healthcare inks deal to launch Avastin biosimilar in MENA markets

Celltrion Healthcare, the marketing unit of Korea's drug developer Celltrion, said on Wednesday that the company inked a partnership with…

Detained Ferrexpo owner resigns from board, Hikma launches ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Hikma launches version of Xyrem medicine in US for treating narcolepsy

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...…

Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.

LONDON (dpa-AFX) - Hikma Pharmaceuticals PLC said that it has launched an authorized generic version of Jazz Pharmaceuticals Xyrem (sodium…

Hikma Pharmaceuticals Launches Xyrem Generic in the U.S.

Hikma Pharmaceuticals Launches Xyrem Generic in the U.S....…

Hikma signs licensing deal with Junshi for toripalimab

Under the deal terms, Hikma will have an exclusive right to develop and market toripalimab injection in all its Middle…

Junshi inks licensing deal with Hikma for toripalimab; FDA filing still under review

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Junshi Biosciences and Hikma Sign Exclusive Licensing Agreement for Cancer Treatment Drug Toripalimab for the Middle East and North Africa Region

SHANGHAI, China, Dec. 26, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE:…

dpa-AFX ProFeed